Vafidemstat rescued cognitive function and reduced the inflammatory signature in the hippocampus of SAMP8 mice, including T-cell receptor b genes and the expression of the alarmin S100a9 [20], an inflammatory biomarker upregulated in several CNS diseases with inflammatory component, including MS [55]. This evidence concerns the gene S100A9 and myeloid sarcoma.